$200–250 million (1,580-1,980 crore) proposal to buy Athenex is being discussed by India’s Intas Pharmaceuticals and Dr. Reddy’s Laboratories since the US-based biotechnology company seems to favour a controlling interest.
In-vitro diagnostic kits that were being marketed illegally in Thane district have been seized by Maharashtra’s Food and Drug Administration (FDA). During a raid at a facility in the Shilphata area, stock valued at Rs 12.40 lakh was taken.
Zydus Lifesciences Ltd announced that it has received final permission from the US Food and Drug Administration to launch its generic version of Ivermectin cream, which is used to treat inflammatory rosacea lesions.
United States Food and Drug Administration has given final approval to Zydus Lifesciences Limited to market Empagliflozin tablets USP 10 mg and 25 mg.
In comparison to a profit of Rs 165 crore in the equivalent quarter of FY 2021–22, Vadodara–based Alembic Pharmaceuticals reported net losses of Rs 65.88 crore for the first quarter of financial year 2022–23.
After Wegovy was introduced in the United States last year, Novo Nordisk was unable to keep up with demand, and the company’s supply problems were made worse when a contract manufacturer had to halt production due to production problems.
European Commission (EC) has given the go-ahead for AstraZeneca (AZ) and MSD’s Lynparza (olaparib) for the treatment of patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website